Results
12
Companies which are more than 50% undervalued based on analyst price target.
12 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BRS | zł5.02 | -2.3% | -19.6% | zł1.0b | zł8.03 | PE56.4x | n/a | 8.8% | Materials | ||
RVU | zł27.60 | -1.3% | -53.2% | zł638.1m | zł57.08 | PS7x | E-6.3% | n/a | Pharmaceuticals & Biotech | ||
PCF | zł9.05 | -1.1% | -63.9% | zł325.3m | zł22.53 | PS1.9x | E84.6% | 0% | Media | ||
CIG | zł1.70 | 5.5% | 0.6% | zł324.4m | zł3.40 | PE17.4x | S4.1% | n/a | Media | ||
CTX | zł51.00 | -3.8% | -45.7% | zł237.8m | zł120.13 | PS12.3x | E71.2% | n/a | Pharmaceuticals & Biotech | ||
GKI | zł2.39 | 21.0% | -12.1% | zł179.1m | zł3.90 | PS0.2x | S12.0% | 0% | Capital Goods | ||
MOC | zł9.20 | 0.5% | -53.4% | zł154.9m | zł18.25 | PS101.8x | E1.4% | n/a | Pharmaceuticals & Biotech | ||
NCL | zł100.00 | 4.3% | -7.4% | zł147.8m | zł189.08 | n/a | n/a | n/a | Materials | ||
VIN | zł9.20 | -1.1% | -25.2% | zł98.4m | zł22.30 | PE7.9x | E11.8% | 4.3% | Commercial Services | ||
NVG | zł1.39 | -1.4% | -48.9% | zł48.5m | zł3.04 | PS9.9x | E62.2% | 4.3% | Diversified Financials | ||
ULG | zł9.20 | -1.3% | -22.7% | zł48.1m | zł17.00 | PS2.1x | n/a | 5.4% | Media | ||
RAE | zł0.38 | -5.7% | -48.8% | zł19.2m | zł1.30 | PB2.2x | S46.8% | n/a | Capital Goods |